Guidelines     MGP Ltd



Forthcoming guidance
 
Published guidance
 
Select guidance type:
Select Clinical speciality:

Date: from to

Search



Title Type Clinical speciality   Expected date   Last updated date
People's experience using adult social care services NICE Quality Standard Public health Dec 2018 Feb 2018
Foetal alcohol spectrum disorder (update) SIGN guidance Paediatrics Dec 2018 Nov 2018
Cerebral palsy in adults NICE Clinical Guideline Neurology Jan 2019 Jan 2019
Combined hormonal contraception—update (Faculty of Sexual & Reproductive Healthcare) Independent professional body guideline Sexual health Jan 2019 Jan 2019
Durvalumab with tremelimumab for untreated EGFR-positive, ALK-negative non-small-cell lung cancer NICE Technology Appraisal Cancer Jan 2019 Sep 2017
Durvalumab for maintenance treatment of unresectable non-small cell lung cancer whose disease has not progressed after platinum-based chemoradiation therapy NICE Technology Appraisal Cancer Jan 2019 Sep 2017
Nivolumab for adjuvant treatment of resected stage III and IV melanoma NICE Technology Appraisal Cancer Jan 2019 Jan 2019
Tisagenlecleucel for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic therapies NICE Technology Appraisal Cancer Jan 2019 -
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal B-cell lymphoma after 2 or more systemic therapies NICE Technology Appraisal Cancer Jan 2019 -
Acute cough (including acute bronchitis): antimicrobial prescribing NICE Clinical Guideline Respiratory Feb 2019 Oct 2018
Contraceptive choices for women who are obese/overweight Independent professional body guideline Sexual health Feb 2019 Jan 2019
Sexual health NICE Quality Standard Sexual health Feb 2019 -
Benralizumab for treating severe asthma NICE Technology Appraisal Respiratory Feb 2019 Dec 2018
Child abuse and neglect NICE Quality Standard Paediatrics Feb 2019 Apr 2018
Serious eye disorders NICE Quality Standard Eye, ear, nose and throat Feb 2019 Apr 2018
Brigatinib for treating ALK-positive non-small-cell lung cancer after crizotinib NICE Technology Appraisal Cancer Feb 2019 Dec 2018
Idelalisib for treating follicular lymphoma refractory to 2 treatments NICE Technology Appraisal Cancer Feb 2019 -
Abemaciclib with an aromatase inhibitor for untreated advanced hormone-receptor positive, HER2-negative breast cancer NICE Technology Appraisal Cancer Feb 2019 Jan 2019
Air pollution: outdoor air quality and health NICE Quality Standard Public health Feb 2019 May 2018
School based interventions NICE Quality Standard Paediatrics Feb 2019 Apr 2018
School based interventions NICE Quality Standard Public health Feb 2019 Apr 2018
Cochlear implants for children and adults with severe to profound deafness NICE Technology Appraisal Eye, ear, nose and throat Feb 2019 Jan 2019
Lung cancer: diagnosis and management (update) NICE Clinical Guideline Cancer Mar 2019 Nov 2018
Intrapartum care for women with existing medical conditions or obstetric complications and their babies NICE Clinical Guideline Women's health Mar 2019 Oct 2018
dasatinib (Sprycel®) All Wales Medicines Strategy Group appraisal Cancer Mar 2019 Dec 2018
ataluren (Translarna®) All Wales Medicines Strategy Group appraisal Musculoskeletal and joints Mar 2019 Jan 2019
Venetoclax in combination with rituximab for treating relapsed or refractory chronic lymphocytic leukaemia NICE Technology Appraisal Cancer Mar 2019 Jan 2019
Pertuzumab for adjuvant treatment of early HER2-positive breast cancer NICE Technology Appraisal Cancer Mar 2019 Jan 2019
blinatumomab (Blincyto®) All Wales Medicines Strategy Group appraisal Cancer Apr 2019 Jan 2019
blinatumomab (Blincyto®) All Wales Medicines Strategy Group appraisal Haematological conditions Apr 2019 Jan 2019
mepolizumab (Nucala®) All Wales Medicines Strategy Group appraisal Respiratory Apr 2019 Jan 2019
doxylamine succinate/pyridoxine hydrochloride (Xonvea®) All Wales Medicines Strategy Group appraisal Women's health May 2019 Jan 2019
Physical activity: encouraging activity within the general population NICE Quality Standard Public health Jun 2019 -
Care and support of people growing older with learning disabilities NICE Quality Standard Neurology Jul 2019 Jan 2019
Hearing loss (adult onset) NICE Quality Standard Eye, ear, nose and throat Jul 2019 Dec 2018
Lyme disease NICE Quality Standard Infection Jul 2019 -
Service model for people with learning disabilities and behaviour that challenges NICE Quality Standard Public health Jul 2019 Dec 2018
Alcohol: school-based interventions NICE Public Health Guidance Paediatrics Aug 2019 Mar 2018
Epilepsy in children (update) SIGN guidance Neurology Aug 2019 -
Asthma (update) SIGN guidance Respiratory Aug 2019 Jun 2018